303 related articles for article (PubMed ID: 11408554)
41. N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat.
Grass S; Hoffmann O; Xu XJ; Wiesenfeld-Hallin Z
Acta Physiol Scand; 1996 Nov; 158(3):269-73. PubMed ID: 8931770
[TBL] [Abstract][Full Text] [Related]
42. Nociceptive behavior induced by poly-L-lysine and other basic compounds involves the spinal NMDA receptors.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Tadano T
Brain Res; 2004 May; 1008(1):49-53. PubMed ID: 15081381
[TBL] [Abstract][Full Text] [Related]
43. Are glycineB sites involved in the development of morphine tolerance?
Kotlińska J
Pol J Pharmacol; 2004; 56(1):51-7. PubMed ID: 15047977
[TBL] [Abstract][Full Text] [Related]
44. Intrathecal antinociceptive interaction between the NMDA antagonist ketamine and the opioids, morphine and biphalin.
Kosson D; Klinowiecka A; Kosson P; Bonney I; Carr DB; Mayzner-Zawadzka E; Lipkowski AW
Eur J Pain; 2008 Jul; 12(5):611-6. PubMed ID: 18068383
[TBL] [Abstract][Full Text] [Related]
45. Effects of NMDA receptor antagonists on acute mu-opioid analgesia in the rat.
Redwine KE; Trujillo KA
Pharmacol Biochem Behav; 2003 Sep; 76(2):361-72. PubMed ID: 14592689
[TBL] [Abstract][Full Text] [Related]
46. Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes.
Tiseo PJ; Cheng J; Pasternak GW; Inturrisi CE
J Pharmacol Exp Ther; 1994 Jan; 268(1):195-201. PubMed ID: 8301558
[TBL] [Abstract][Full Text] [Related]
47. ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50,488H in the tail flick test in mice.
Lutfy K; Doan P; Nugyen M; Weber E
Pharmacol Res; 1998 Dec; 38(6):453-60. PubMed ID: 9990654
[TBL] [Abstract][Full Text] [Related]
48. Nociception increases during opioid infusion in opioid receptor triple knock-out mice.
Juni A; Klein G; Pintar JE; Kest B
Neuroscience; 2007 Jun; 147(2):439-44. PubMed ID: 17544222
[TBL] [Abstract][Full Text] [Related]
49. Anti-allodynic interactions between NMDA receptor channel blockers and morphine or clonidine in neuropathic rats.
Malyshkin AA; Medvedev IO; Danysz W; Bespalov AY
Eur J Pharmacol; 2005 Sep; 519(1-2):80-5. PubMed ID: 16109402
[TBL] [Abstract][Full Text] [Related]
50. Increased efficacy of micro-opioid agonist-induced antinociception by metabotropic glutamate receptor antagonists in C57BL/6 mice: comparison with (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959).
Fischer BD; Miller LL; Henry FE; Picker MJ; Dykstra LA
Psychopharmacology (Berl); 2008 Jun; 198(2):271-8. PubMed ID: 18392754
[TBL] [Abstract][Full Text] [Related]
51. The NMDA antagonist MK-801 induces hyperalgesia and increases CSF excitatory amino acids in rats: reversal by guanosine.
Schmidt AP; Tort AB; Silveira PP; Böhmer AE; Hansel G; Knorr L; Schallenberger C; Dalmaz C; Elisabetsky E; Crestana RH; Lara DR; Souza DO
Pharmacol Biochem Behav; 2009 Feb; 91(4):549-53. PubMed ID: 18854198
[TBL] [Abstract][Full Text] [Related]
52. Role of morphine maintenance dose in the development of tolerance and its attenuation by an NMDA receptor antagonist.
Allen RM; Dykstra LA
Psychopharmacology (Berl); 2000 Jan; 148(1):59-65. PubMed ID: 10663418
[TBL] [Abstract][Full Text] [Related]
53. Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice.
Ribeiro Do Couto B; Aguilar MA; Manzanedo C; Rodríguez-Arias M; Miñarro J
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1035-43. PubMed ID: 15380865
[TBL] [Abstract][Full Text] [Related]
54. Antinociceptive effects and synergistic interaction with morphine of intrathecal metabotropic glutamate receptor 2/3 antagonist in the formalin test of rats.
Yoon MH; Choi Jl; Bae HB; Kim SJ; Chung ST; Jeong SW; Chung SS; Yoo KY; Jeong CY
Neurosci Lett; 2006 Feb; 394(3):222-6. PubMed ID: 16293369
[TBL] [Abstract][Full Text] [Related]
55. The role of serotonergic receptors in the effects of mu opioids in squirrel monkeys responding under a titration procedure.
Powell KR; Dykstra LA
Psychopharmacology (Berl); 1996 Jul; 126(1):42-9. PubMed ID: 8853215
[TBL] [Abstract][Full Text] [Related]
56. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
Sterious SN; Walker EA
J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
[TBL] [Abstract][Full Text] [Related]
57. Antagonism of N-methyl-D-aspartate receptors reduces the vulnerability of the immune system to stress after chronic morphine.
Alonzo NC; Bayer BM
J Pharmacol Exp Ther; 2003 Nov; 307(2):793-800. PubMed ID: 12966157
[TBL] [Abstract][Full Text] [Related]
58. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. II. Assessment of the antinociceptive activity of combinations of competitive and non-competitive NMDA antagonists with agents acting at allosteric-glycine and polyamine receptor sites.
Coderre TJ; Van Empel I
Pain; 1994 Dec; 59(3):353-359. PubMed ID: 7708409
[TBL] [Abstract][Full Text] [Related]
59. Chronic morphine treatment alters N-methyl-D-aspartate receptors in freshly isolated neurons from nucleus accumbens.
Martin G; Guadaño-Ferraz A; Morte B; Ahmed S; Koob GF; De Lecea L; Siggins GR
J Pharmacol Exp Ther; 2004 Oct; 311(1):265-73. PubMed ID: 15263066
[TBL] [Abstract][Full Text] [Related]
60. Involvement of glutamatergic receptors in the nucleus cuneiformis in modulating morphine-induced antinociception in rats.
Haghparast A; Gheitasi IP; Lashgari R
Eur J Pain; 2007 Nov; 11(8):855-62. PubMed ID: 17291798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]